Science and practice of the diagnosis, treatment, and prevention of physical and mental illnesses
POPULARITY
Part Two of So Shameless featuring Kizzle of @expressyourselfblackman and life coach Coach Bellamy (@mrsbellamy.callmecoach) gets personal as we talk about insecurity, fatherhood, relationships, responsibility and some uncomfortable truths about ourselves. We start with something almost everybody experiences but doesn't always admit: feelings of inadequacy. What do you do when you don't feel like you're enough? And how much of overcoming those feelings comes from changing your circumstances versus changing the way you see yourself? Then we get into fatherhood and discipline. What happens when Dad constantly feels like the bad guy because he's the parent enforcing the rules? Are fathers sometimes sacrificing their relationship with their children in order to prepare them for the real world? From there, Tahoe asks a question that's guaranteed to start an argument: When your woman is pregnant, should she still have to work — or is it a man's responsibility to put himself in a position where she doesn't HAVE to? And does providing that option make it her choice, or should that simply be the expectation? Then things get even more complicated. Does being in a relationship mean you belong to your partner in some way? Are you your partner's “possession,” or does that language cross a line between commitment and control? We also talk about preparing your children for what happens after you're gone. Should your kids know what they're inheriting while you're still alive, or should they find out when the will is read? And can knowing what's coming change the way family members behave? Finally, we ask one of the most uncomfortable relationship questions of the episode: Can you be partially responsible for your partner cheating on you? The person who cheats is responsible for the decision they make — but can problems inside a relationship help create the circumstances that lead someone to step outside of it? And is understanding what went wrong the same thing as excusing the betrayal? Insecurity. Fatherhood. Pregnancy. Providing. Possession. Inheritance. Infidelity. Yeah…Part Two went there. Welcome back to So Shameless.SocialsMrs Bellamy @MrsBellamy.CallMeCoach on InstagramKizzle@ExpressYourselfBlackMan on Instagram
Medical training hands you a ready-made group of friends. Then it ends, and many women physicians find themselves starting over alone in a new city. Cassie Burton Greenbaum is a pediatric critical care physician and the founder of Off Service Mom Co., a friendship matchmaking service for physician moms. This episode is based on her article "Physician loneliness is driving women out of medicine," published on KevinMD. You will hear why friendships get harder to build once you are the attending, and how a schedule with no pattern to it pulls you away from everyone who works ordinary hours. She explains how chronic loneliness turns into burnout and lost career satisfaction, and how the shame around the word lonely keeps physicians from ever saying it out loud. She describes the six-week pilot she ran with 20 physician moms and what made the matches work. Press play for the specific moves she recommends, starting with the reason that waiting until you feel less busy never works. This episode is brought to you by ModMed. Welcome to your new AI-Powered Practice from ModMed. We're transforming specialty care by embedding AI Assistants across your entire workflow. Our all-in-one platform of EHR, patient engagement, practice management, and RCM helps reduce repetitive work while keeping you firmly in control. Trained on de-identified data from nearly a billion patient encounters, this isn't just smarter software. It's a new way of working for specialty medicine, more efficient and more connected to the patient experience. Start building your AI-Powered Practice at modmed.com. VISIT SPONSOR → https://www.modmed.com/ SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
This week we explore a recent PHIS database study assessing clinical outcomes for transcatheter balloon dilation of the aortic valve in the setting of aortic valve stenosis in early life. Why do critical AS patients fare less well than those with severe AS? Is this an issue of procedural failure or patient characteristics? Is there adequate equipoise for a study comparing surgery to balloon dilation? Is such a study even feasible given the present day levels of surgical experience with neonatal aortic valve surgery? These are amongst the questions posed to Associate Professor of Pediatrics at Vandarbilt University, Dr. George Nicholson who is the senior author of this week's work. DOI: 10.1007/s00246-026-04196-1
Send us Fan MailDoes Tylenol in pregnancy cause autism or ADHD? In this edition of Neo News, Ben and Eli break down a major JAMA Internal Medicine study from Hong Kong that followed hundreds of thousands of mother-child pairs and used a sibling-matched design to answer the question. The verdict: no association between prenatal acetaminophen exposure and autism spectrum disorder or ADHD, regardless of timing, pattern, or dose. But data alone doesn't win hearts. The conversation turns to the bedside: how do we explain study methodology to families without dismissing their concerns? Eli shares his approach to vaccine hesitancy in the NICU, built on continuity, persistence, and transparency, and draws lessons from journalism about corrections, trust, and why showing up matters. Tune in.----Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts. Luo S, Gong Q, Ai Y, Zhang J, Chan L, Wong WCW, Ip P, Chan EWY, Tanuseputro P, Wong ICK, Wan EYF.JAMA Intern Med. 2026 Sep 1;186(9):1102-1111. doi: 10.1001/jamainternmed.2026.2215.PMID: 42371637Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!
Jody Hamilton steps in for Stephanie Miller to help you navigate the political circus without losing your mind. She tackles the FCC's absurd free-speech crackdown, President Trump's Fox News feud, and Pete Hegseth's military rants. Medical expert Dr. Irwin Redlener stops by to unpack AI in healthcare and Ukraine's impending winter, while comedian Dana Goldberg brings the razor-sharp laughs. Tune in for the ultimate mix of news, wit, and sanity.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
If you have Hashimoto's or hypothyroidism (low thyroid), you've probably heard about certain foods you should avoid. But what if a thyroid-friendly diet is less about cutting out gluten, dairy, and other foods, and more about making sure your thyroid has the right nutrients it needs to thrive?In this episode, we're challenging common thyroid diet rules and exploring foods for thyroid health, plus how to build simple, nutrient-dense meals without turning meals into another source of stress. We'll also discuss controversial thoughts on thyroid medication, why your TSH doesn't tell the whole story, and the surprising connections between low thyroid function and chronic skin issues.Ginny Mahar, FMCHC joins me on the show. She is a Le Cordon Bleu-trained chef, Functional Medicine Certified Health Coach, creator of Hypothyroid Chef, and author of the THYROID30® Cookbook. After her own diagnoses of hypothyroidism and Hashimoto's, Ginny combined her culinary background with nutrition and coaching to help others make thyroid-friendly eating practical, nourishing, and delicious.⭐️Mentioned in This Episode:- See all the references
Today's episode features conversations grounded in movement. First, we check in with a doctor whose new book explores the impacts of nontraditional medicines – like dance, food and community – on our cognitive health. Plus, we sit down with Evanston mother Megan Lassman about training to run and push her 21-year-old daughter in a stroller in the Chicago Marathon.GUESTS: Dr. Geeta Maker-Clark, author of Medicine for All People: Science and Ancient Wisdom for Revolutionary HealingMegan Lassman, Evanston motherFor a full archive of In the Loop interviews, head over to wbez.org/intheloop.
Does a "high-risk pregnancy" mean something will go wrong? Fetal medicine specialist Panicos Shangaris of King's College Hospital speaks with Brigitte Cutshall; he explains how the label works, why preconception counseling matters, and how AI is changing prenatal care.3 Takeaways(1) "High risk" means more support, not bad news. It brings in the right specialists and a plan built for you.(2) Start before the positive test. Preconception checks like iron, vitamin D, thyroid, and weight help you begin pregnancy healthier.(3) AI buys time for the human part. Faster scans and letters leave doctors more time to counsel and comfort.Connect with Dr. Panicos Shangaris:• Website: https://shangaris.com/• Instagram: https://www.instagram.com/londonpregnancyob/• LinkedIn: https://www.linkedin.com/in/panicos-shangaris/
Send us Fan MailIn this Journal Club episode, Daphna reviews the first national estimate of potential neonatal organ donors, a Pediatrics cohort study from 23 Australian NICUs, along with its companion commentary. Of 1,760 infants who died in the NICU between 2012 and 2022 at 35 weeks corrected age or later, about one in three met conservative eligibility criteria. Most would have donated after circulatory death, and a smaller group with severe HIE could potentially have donated after neurological determination of death. They discuss referral timing, outcomes of en bloc kidney transplants from neonatal donors, and how NICUs can offer families this option as part of end-of-life care.----Potential Neonatal Donors in Australia: A National Cohort Study. Barzegar R, Cavazzoni E, Popat H, Wong G.Pediatrics. 2026 Sep 3:e2025075110. doi: 10.1542/peds.2025-075110. Online ahead of print.PMID: 42686207The Untapped Potential of Organ Donation from the NICU. Nguyen BV, Coloma M, Crouch EE.Pediatrics. 2026 Sep 3:e2026076954. doi: 10.1542/peds.2026-076954. Online ahead of print.PMID: 42686210 No abstract available.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!
In this episode of the Observatory Podcast, Scott and LaRae Wright sit down with Dr. Stormy Hill for a deeply personal conversation about aliveness, intimacy, sensuality, pleasure, and what it means to fully participate in your own life. Stormy shares the unexpected path that took her from medicine to occupational therapy and intimacy coaching, including her son's serious heart condition, the end of her marriage, and her discovery of Tantra and sacred sexuality as pathways toward embodiment, connection, and a more expansive understanding of intimacy.As Stormy approaches her 50th birthday, the conversation turns toward the second half of life, relationships, nervous-system patterns, what she calls “adaptive inertia,” and the ways we can unknowingly adapt to lives that make us smaller. She also shares her recent 85-mile hike around Mont Blanc, her return to writing poetry after nearly 25 years, and why she is shifting her measure of a meaningful life away from achievements and toward awe, creativity, receptivity, pleasure, and the question: what makes you feel most alive?Timestamps:[00:00:03] Welcome to The Observatory Podcast[00:00:18] Introducing Dr. Stormy Hill and the pursuit of aliveness[00:03:43] Expanding intimacy, pleasure, and sensuality beyond the bedroom[00:05:14] Approaching 50 and discovering the common thread of aliveness[00:07:46] Medicine, motherhood, and her son's rare heart condition[00:14:45] Tantra, sacred sexuality, embodiment, and the divine[00:19:18] Growth, the nervous system, and “adaptive inertia”[00:25:08] The second half of life, relationships, and creating what comes next[00:30:08] Turning 50, resilience, and hiking Mont Blanc[00:38:12] One long blink of a life and helping people feel more alive[00:40:02] Keeping score with the wrong scorecard[00:49:24] What makes you feel alive and the practice of intentional participation[00:52:05] Poetry, grief, and rediscovering creative expression[00:58:24] Letting go, receptivity, and making room for what comes next[01:03:29] Living now instead of waiting for laterNotable Quotes:“We are wired for growth, but we are also wired for pattern recognition.” - Dr. Stormy Hill [00:20:26]“We give this one long blink of an eye of a life if we're lucky, and how do we bring aliveness and pleasure and joy to it?” - Dr. Stormy Hill [00:38:14]“I was keeping score with the wrong scorecard.” - Dr. Stormy Hill [00:40:02]“What makes you feel most alive? What keeps you from feeling alive? And how about we do more of what makes us feel more alive?” - Dr. Stormy Hill [00:50:02]“You arrive in innocence, you lose your innocence, and then at a certain point in life you realize that you've been innocent all along.” - Scott Wright [00:57:40]“Nobody on their deathbed says they wish they worked more.” - Dr. Stormy Hill [01:03:29]Relevant Links:www.Instagram.com/docstormy1 — on IG for more on aliveness www.Drstormyschiller.com — for speaking inquiries www.Lovedeeplab.com — for intimacy coachingSubscribe to the podcast: Apple PodcastsProduced by NC Productions!
The benefits of kimchi for detoxing microplasticsWhat do you recommend my husband take to recover from Bell's Palsy? Follow-up on coronary artery inflammation question
The benefits of PilatesWhat does it mean that certain brands of nattokinase are "free of K2"?Should I avoid soy products due to my history of breast cancer?How can I choose the best fish oil? Is there a certain dose you recommend?Is there any other supplement I can take besides 5-HTP for mood? What about SAMe?Is there any relief for my friend with ulcerative colitis?
Send us Fan MailShe was a Sunday school teacher who showed up to church hungover most weeks. Not partying. She says the alcohol was medicine, the equivalent of a bottle of Xanax at the end of a long day.Yolanda Gray was the oldest of six girls in a difficult home, a teenage mother, and a woman in a hard marriage for almost twenty years. Sobriety came first. Seven years later, everything else changed.Three things you will take from this one.Our secrets keep us sick. She spent years trying to stop on her own because she was ashamed, and it was telling the truth that finally moved her.You cannot take back a life you do not believe is yours. Identity comes before the choice.Rest is not optional. Shingles laid her out for fifteen months, and she says the hustle we were sold is a lie.Her book is Take Back Your Life is available by clicking here.Find her at yolandagrey.comShare this episode with the woman who came to mind while you were listening.Register Click HERE: The Calling Activation Study; Discover the Story That Connects Your Calling to the People You're Meant to Serve.To be a guest on the Calling series: https://theresacroft.com/your-seatHome TheresaCroft.comInstagram: https://instagram.com/theresacroftFacebook: https://Facebook.com/theresamcroftYouTube: https://YouTube.com/@theresacroftMore Podcast Episodes on Apple and Spotify
This week on On The Pen, The Weekly Dose, we break down one of the biggest weeks in obesity medicine coming out of EASD 2026.Eli Lilly says Zepbound may still outperform Wegovy 7.2 mg, even after Novo Nordisk tripled the familiar maintenance dose, but the details are more complicated than the headline. We dig into the difference between the treatment-regimen and efficacy estimands, and why this was not a true head-to-head trial.We also cover Novo Nordisk's $2.6 billion bet on a potential once-weekly oral GLP-1/GIP, new Foundayo data against high-dose oral semaglutide, Viatris and Mylan's renewed patent fight over the future of generic Wegovy, and the full Phase 3 retatrutide publication in the New England Journal of Medicine.Plus, after weeks of concern over GLP-1 medications and NAION-related vision loss, we look at one practical thing patients may be able to do right now to better understand their own baseline risk.This episode is about more than who “wins” between Lilly and Novo. It is about what the data actually says, where the next generation of obesity treatment is headed, and what all of this means for patients trying to make informed decisions with their doctors.Covered in this episode: Zepbound vs. Wegovy 7.2 mg, retatrutide TRIUMPH-1 Phase 3 data, Foundayo/orforglipron, oral semaglutide, once-weekly oral GLP-1s, generic Wegovy patent litigation, NAION, GLP-1 vision risk, EASD 2026, Eli Lilly, Novo Nordisk, Viatris and Mylan.Subscribe for breaking GLP-1, obesity, diabetes and metabolic-health news, explained from the patient perspective.Get Exclusive OTP Savings and Resrouces:Https://www.otplinks.comGet Breaking Obesity Medicine News:HTTPS://www.onthepen.com
Dr. Kate Bailey, vice president of medical excellence and education at MedVet and a board-certified veterinary anesthesiologist, is our guest this week. From plans to pursue equine surgery to discovering a passion for anesthesiology, teaching, and medical quality, Dr. Bailey reflects on how mentorship, new experiences, and an openness to changing direction shaped each step of her career. She also shares why we shouldn't feel pressured to find the “perfect” job right away and how focusing on what matters most to you can open the door to opportunities you never knew existed.Thank you to our podcast partner Hill's Pet Nutrition! You can find more information about Hill's Pet Nutrition at https://www.hillspet.com/ and https://www.hillsvet.com/.
Fluent Fiction - Hungarian: When Two Worlds Collide: Art and Medicine Unite in Healing Find the full episode transcript, vocabulary words, and more:fluentfiction.com/hu/episode/2026-10-01-22-34-01-hu Story Transcript:Hu: A fák aranyló levelei szálltak az enyhén csípős őszi szélben, miközben Ákos belépett a budapesti tábori kórházba.En: The golden leaves of the trees floated in the slightly biting autumn wind as Ákos entered the field hospital in Budapest.Hu: Az épület körül sürgés-forgás, de belül a káosz egy különleges rendet rejtett.En: There was bustling around the building, but inside, the chaos held a special order.Hu: Az orvostanhallgató Ákos megigazította a köpenyét, igyekezett összpontosítani.En: The medical student, Ákos, adjusted his coat, trying to concentrate.Hu: Nagy elvárások nehezedtek a vállára, hiszen mindenki az ő családjának orvos dinasztiájához mérte őt.En: Great expectations weighed on his shoulders, as everyone measured him against his family's medical dynasty.Hu: Zsófia, az ifjú művész, már várta a recepciónál.En: Zsófia, the young artist, was already waiting at the reception.Hu: Önkéntesként dolgozott, hogy inspirációt találjon.En: She volunteered to find inspiration.Hu: A zsúfoltság ellenére mosolygott, és minden pillanatot megfigyelt, mint egy képet készítő festő.En: Despite the crowd, she smiled and observed every moment like a painter creating a picture.Hu: Amikor Ákos megérkezett, azonnal felkeltette a figyelmét.En: When Ákos arrived, she immediately became interested.Hu: Volna benne valami titokzatos, amit Zsófia meg akart érteni.En: There was something mysterious about him that Zsófia wanted to understand.Hu: "Nehéz napunk lesz" - kezdte Ákos, kicsit mereven, miközben köszöntötte Zsófiát.En: "We'll have a tough day," Ákos began, somewhat stiffly, while greeting Zsófia.Hu: "Neked van már tapasztalatod, ugye?"En: "You have experience, right?"Hu: "Nem egészen ilyen jellegű" - kacagott Zsófia.En: "Not quite of this kind," laughed Zsófia.Hu: "De kíváncsian várom, mit tanulhatok."En: "But I'm curious to see what I can learn."Hu: Ahogy teltek a napok, Zsófia egyre inkább próbálta meglepni a merev, professzionális Ákost, de nehéz volt áttörni a falat.En: As the days went by, Zsófia increasingly tried to surprise the stiff, professional Ákos, but it was hard to break through the wall.Hu: Ákos otthon érezte a nyomást, hogy tökéletes legyen.En: Ákos felt the pressure at home to be perfect.Hu: Zsófia pedig azt kívánta, hogy Ákos mögé lásson a merev külsőnek.En: Zsófia wished to see through the stiff exterior of Ákos.Hu: Egy délután, amikor a szél már hidegebbre fordult, és a nap alacsonyabban járt, sürgős hívás érkezett a kórházba.En: One afternoon, when the wind turned colder, and the sun was lower in the sky, an urgent call arrived at the hospital.Hu: Egy sérült beteg behozatala mindenkit mozgósított.En: The arrival of an injured patient mobilized everyone.Hu: Ákos és Zsófia együtt indultak segíteni.En: Ákos and Zsófia set out together to help.Hu: Ákos gyors mozdulatokkal dolgozott, de a szemei alatt feszültség ült.En: Ákos worked quickly, but tension settled under his eyes.Hu: Zsófia megfogta Ákos kezét, szemébe nézett és azt mondta: "Bízz bennem. Együtt megoldjuk."En: Zsófia took Ákos's hand, looked into his eyes, and said, "Trust me. We'll solve it together."Hu: A szavai, mintha varázserővel bírtak volna.En: Her words seemed to have a magical power.Hu: Ákos hirtelen nyugodtabbnak érezte magát, és mindketten egy hullámhosszon kezdtek dolgozni.En: Ákos suddenly felt calmer, and both began working in harmony.Hu: Az esemény hevében Ákos beszélni kezdett Zsófiának a félelmeiről és a családi nyomásról, ami folyton súlyosbította terheit.En: In the heat of the moment, Ákos started to talk to Zsófia about his fears and the family pressure that constantly aggravated his burdens.Hu: Zsófia megértette, mennyit jelent neki ez a pillanat, és nem minősítette, csak hallgatta.En: Zsófia understood how much this moment meant to him, and she didn't judge, just listened.Hu: A krízis végére közelebb kerültek egymáshoz.En: By the end of the crisis, they had grown closer.Hu: Ákos új fényt vetett Zsófia szemében; egyszerre volt törékeny és erős.En: Ákos shone a new light in Zsófia's eyes; he was both fragile and strong.Hu: Zsófia mélyebb érzéseket fedezett fel, melyeket eddig csak festményein keresett.En: Zsófia discovered deeper feelings, which she had previously only sought in her paintings.Hu: Aznap este, ahogy a nap narancssárgán festette be Budapest égboltját, elhatározták, hogy a jövőben is együtt dolgoznak.En: That evening, as the sun painted the sky of Budapest orange, they decided they would continue working together in the future.Hu: Az őszi levelek alatt a kórház előtt Ákos elégedetten sóhajtott.En: Under the autumn leaves in front of the hospital, Ákos sighed contentedly.Hu: Előtette a telefonját, felhívta családját és elmesélt nekik mindent.En: He took out his phone, called his family, and told them everything.Hu: Rájött, hogy a sebezhetőség gyakran a legnagyobb erősség, a kapcsolat pedig az, ami igazán gazdagítja az életét.En: He realized that vulnerability is often the greatest strength, and connection is what truly enriches life.Hu: Zsófia pedig megtalálta azt az inspirációt, amire igazából vágyott.En: Zsófia found the inspiration she really longed for.Hu: Két különböző világ találkozását, ami a legszebb festményei sorába kerülhetett volna.En: The meeting of two different worlds, which could have been among her most beautiful paintings. Vocabulary Words:biting: csípősbustling: sürgés-forgáschaos: káoszexpectations: elvárásokdynasty: dinasztiareception: recepcióvolunteer: önkéntesmysterious: titokzatosstiffly: merevenexperience: tapasztalatcurious: kíváncsiexterior: külsőurgent: sürgősmobilized: mozgósítotttension: feszültségtrust: bízikharmony: harmóniafears: félelmekaggravated: súlyosbítottavulnerability: sebezhetőségconnection: kapcsolatenriches: gazdagítjainspiration: inspirációfragile: törékenyurgent call: sürgős híváscontended: elégedettensolved: megoldjukobserved: megfigyeltpainter: festőburdens: terhek
Nach einem langen und intensiven Sommer, der voll war mit Reisen, Erlebnissen und Unterwegs-Sein, haben Isabel und Lukas eine Entscheidung getroffen: zurückschrauben. Mehr kochen, weniger Restaurants, weniger Termine — nicht aus Askese, sondern weil Reizüberflutung auch im echten Leben passiert. Die Kinder werden größer, und damit kommen neue Fragen. Vitos erste Schularbeit ist der Aufhänger für eine grundsätzlichere Diskussion: Nachhilfe organisieren oder selbst dranbleiben? Isabel und Lukas sind sich einig — guter Coach sein ist nicht delegierbar, zumindest nicht in dieser Phase. Selbstvertrauen entsteht nicht durch bessere Noten, sondern dadurch, dass man selbst durch die Schwierigkeit gegangen ist. C.G. Jung hatte recht: alles bis 40 ist Übung. Lukas erzählt, dass er sich seit wenigen Jahren zum ersten Mal wirklich als eigenständiger Unternehmer fühlt — keine Verantwortung nach oben, keine nach unten, nur nach innen. Dann: das Otto Wagner Areal. Isabel und Lukas waren beim Performance-Theaterstück “Ganymed Areal” von Jacqueline Kornmüller und waren hellauf begeistert. Ihr persönliches Highlight waren Federspiel, ein Wachauer Blasmusik-Ensemble, die, während du mit einem Hocker durch das ehemalige Psychiatrie-Areal wanderst, neben dir beginnen zu spielen. Lukas findet dafür nur ein Wort: bewegend. Außerdem: Matthias Döpfner, CEO von Axel Springer, meint im Interview gegenüber Peter Thiel: "Progress in Medicine is the only thing that has no downside." Ein Satz, der hängenbleibt. Und ob man ewig leben wollen würde?
Nutrition advice often reduces food to calories, nutrients, and a list of rules to follow. But the more we learn about how the body responds to different foods, the clearer it becomes that this way of thinking tells only part of the story. Today, I'm joined by cardiologist and public health expert Dr. Dariush Mozaffarian, director of the Food is Medicine Institute at Tufts University and author of the new book Food Is Medicine. We explore what we still get wrong about food and what changes when we begin treating it more like medicine. Here's what we discuss: Why eating less and exercising more may not lead to lasting weight loss, and what to focus on instead How to choose foods that work with your appetite, metabolism, and microbiome rather than relying on calorie counting What GLP-1 medications can teach all of us about hunger, cravings, and why weight isn't simply about willpower How much protein you actually need and why the source matters What the science says about seed oils and which processed foods are worth avoiding Over the years, I've learned to focus less on counting calories or chasing a single nutrient and more on the quality of the food itself. When you eat real, whole foods, the signals that regulate hunger and energy can begin to work with you instead of against you. Eating well should be less about following rules and more about understanding what helps your body function at its best. View Show Notes From This Episode Sign up for Dr. Hyman's Brainshaping Academy to learn how to nourish the biological systems that support your mental, emotional, and cognitive health https://drhyman.com/products/brainshaping?utm_source=dr_hyman_show&utm_medium=newsletter&utm_campaign=may_27&utm_content=link Get Free Weekly Health Tips from Dr. Hymanhttps://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journalhttps://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Healthhttps://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Resultshttps://drhyman.com/pages/hyman-hive This episode is brought to you by Cozy Earth, Made In, Fatty15, Pique, Paleovalley, and BIOptimizers. Upgrade your sleep setup with cozyearth.com and enjoy 20% off with code HYMAN. Explore kitchen essentials at madeincookware.com and save 10% off your first order with code HYMAN-HIVE. Head to fatty15.com/HYMAN today and use code HYMAN for 15% off your 90-day subscription Starter Kit. Elevate your daily wellness ritual at piquelife.com/hyman and enjoy 20% off plus free gifts. Shop nutrient-rich foods and supplements at paleovalley.com/hyman and save 15% off your first order. Shop Magnesium Breakthrough at bioptimizers.com/hyman and save 15% with code HYMAN. 0:00 The paradox of rising obesity, calorie intake, and the importance of food quality over willpower 2:00 Introduction to Food is Medicine and Dr. Hyman's mission 4:25 How medical training ignored nutrition and early challenges to low-fat dogma 7:48 Cardiac diets, processed carbs, and failures in nutrition science translation 10:54 The food system's role in chronic disease and its national impact 12:15 Food as a health, economic, environmental, and equity issue 15:05 How science, policy, and business shaped the modern food system 18:14 Fixing the food system using the same forces that created it 19:04 The birth of modern nutrition science and discovery of vitamins 20:15 Deficiency diseases, vitamin fortification, and enriched grains 23:16 The green revolution, famine fears, and calorie-focused agriculture 27:04 Low-fat advice, tobacco-era marketing, and the rise of ultra-processed food 31:29 Misapplied nutrient thinking: fat vilification and chronic disease 33:30 Why calories in, calories out fails for obesity and weight control 36:53 Thermogenesis, brown fat, and food quality's impact on metabolism 39:25 The microbiome's role in calorie harvesting and weight regulation 41:03 Real food vs. calorie counting for long-term weight control 43:09 GLP-1, the microbiome, and how the food system hijacks appetite 48:27 Feeding your inner garden: microbiome foods, prebiotics, and protective foods 50:47 Food as medicine: adding good foods vs. deprivation 52:36 Food as a fast, personalized therapy for chronic disease 54:11 What ultra-processed food is and why it's harmful 59:59 Why junk food isn't food, and the protein craze explained 1:00:44 How much protein you need and why the source matters 1:03:55 Best protein sources and the dangers of processed meats 1:05:58 Seed oils, trans fats, omega-6s, and omega-3 deficiency 1:13:57 Why food system change is needed, not just individual willpower 1:15:20 Policy levers for fixing agriculture, labeling, regulation, and nutrition science 1:17:29 How health care can drive food as medicine 1:21:58 How investing in healthy food can reshape markets and outcomes 1:22:44 Food industry lobbying, misinformation, and policy challenges 1:25:07 Business innovation to shift toward healthier food products 1:26:03 Ultra-processed foods as “coal” and replacing them with clean food 1:26:25 What listeners can do in their communities and with officials
In episode 2133, Miles and guest co-host Matt Lieb are joined by Pod Yourself A Gun & Mad Yourself A Man, Vince Mancini, to discuss… This Year’s “MAHA Summit” Is Full Of Celebrity Dirtbags, Zoomer on TikTok says that MILLENNIALS are preventing their generation from working, Gov Abbott DECLARES (makes empty gesture) DIESEL DISASTER! A Long-Dead Sci-Fi Writer Probably Shouldn’t Be In Charge Of AI Safety and more! Vance, RFK Jr. and 'Iron' Mike to headline MAHA Summit Dr. Oz to Appear On a Panel Moderated by Russell Brand — Who is Currently Facing Rape Charges in the UK The Benefits of Snake Oil - Dr.Berg Isaac Asimov Showed Us How to Avoid the AI Apocalypse One of science fiction’s greatest writers warned us about AI. Could his ideas help us avoid a dystopian future? Could revisiting Asimov’s laws help us avoid AI’s ‘Chernobyl moment’? Noted Brain Genius Tyler Winklevoss Thinks Isaac Asimov Already Solved the AI Apocalypse Google Taps Asimov's Three Laws of Robotics for Real Robot Safety Asimov's Laws Won't Stop Robots from Harming Humans, So We've Developed a Better Solution What Isaac Asimov Reveals About Living with A.I. “Runaround” In: I, Robot by Isaac Asimov Runaround By Isaac Asimov Elon Musk, Sam Altman, and the Misreading of Science Fiction LISTEN: Blend by BrainstorySee omnystudio.com/listener for privacy information.
America spends nearly a fifth of its economy on health care, yet chronic disease keeps rising and prevention lags. Narinder Singh Parhar, an internist and intensivist with four decades of experience across outpatient, hospital, and ICU care, argues that American medicine has grown top-heavy, brilliant at acute rescue but neglectful of the everyday habits that keep people well. This episode is based on his article "Why scientific medicine alone is not making us healthier," published on KevinMD. You will hear why splitting the body into specialties can lose sight of the whole person, how a few minutes a day of simple exercise may reduce falls and even ease sleep apnea, and why cutting back on unnecessary medications matters as you age. You will also hear his case for paying and respecting primary care physicians more and letting nurses and therapists help patients build lasting habits. Press play to hear which small, repeatable habits he believes do the most to keep you healthy. This episode is brought to you by ModMed. Welcome to your new AI-Powered Practice from ModMed. We're transforming specialty care by embedding AI Assistants across your entire workflow. Our all-in-one platform of EHR, patient engagement, practice management, and RCM helps reduce repetitive work while keeping you firmly in control. Trained on de-identified data from nearly a billion patient encounters, this isn't just smarter software. It's a new way of working for specialty medicine, more efficient and more connected to the patient experience. Start building your AI-Powered Practice at modmed.com. VISIT SPONSOR → https://www.modmed.com/ SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
Send us Fan MailIn this Journal Club episode, Ben reviews a JAMA Network Open study from two Dutch Level IV NICUs. It examined NEC before and after routine implementation of a three-strain probiotic in 1,413 infants born before 30 weeks or under 1,000 grams. NEC fell from 11.9% to 5.3%, and late-onset sepsis also declined. But non-NEC mortality rose after implementation. NEC also dropped in an unexposed reference cohort, and one infant died of B. infantis sepsis. Ben and Daphna discuss how baseline NEC rates, seasonal patterns, and number needed to harm should shape how units weigh probiotic use.----Probiotic Implementation and Necrotizing Enterocolitis Risk in Preterm Infants. Imren C, Jongejans V, Onland W, Keyzer-Dekker CMG, Been JV, Derikx JPM, van Kaam AH, Simons SHP, Twisk JWR, van den Akker CHP, Vermeulen MJ.JAMA Netw Open. 2026 Aug 3;9(8):e2631601. doi: 10.1001/jamanetworkopen.2026.31601.PMID: 42671836 Free PMC article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!
This week, we feature new research on statin therapy in older adults, treatments for IgG4-related disease and advanced breast cancer, and a once-weekly oral regimen for HIV. We review Andes virus and follow a challenging case of a disseminated infection. Articles explore scientific independence, opioid-settlement funds, pharmaceutical policy, and the role of community in patient care.
Dr. Hoffman continues his conversation with Dr. Jeffrey Bland, founder of the Personalized Lifestyle Medicine Institute and Big Bold Health, about fish oil and omega-3 science.
Fish Oil, Full-Spectrum Omega-3s, and Immunometabolism with Dr. Jeffrey Bland: Dr. Ronald Hoffman interviews Dr. Jeffrey Bland, founder of the Personalized Lifestyle Medicine Institute and Big Bold Health, about fish oil and omega-3 science. Bland recounts becoming involved with commercial fish oil in 1980 while promoting MaxEPA amid the “fat is bad” era and discusses Greenland Inuit research showing high omega-3 blood levels and low heart disease. They contrast whole-food omega-3 intake with highly refined EPA/DHA products, highlighting additional constituents in minimally processed oils (vitamins A and D, astaxanthin) and precursor compounds related to specialized pro-resolving mediators. Bland describes Omega-3 Rejuvenate's Alaska line-caught sourcing and low-heat, chemical-free processing, and addresses concerns about mercury, microplastics, and vitamin A dosing. The conversation also covers PLMI's focus on immunometabolism, a CBC-derived SIRI marker, omega-3 insufficiency data from Fullscript, mitochondrial membrane support by DHA, and Bland's upcoming book, “The Nourished Gene.”
The Psychedelic Entrepreneur - Medicine for These Times with Beth Weinstein
Download my free training, The Real Reason You Still Feel Blocked...No Matter How Much "Inner Work" You've Done. here: https://go.bethaweinstein.com/unblocked Episode Highlights▶ Integration of multidimensional modalities in business▶ The importance of inner work and subconscious reprogramming▶ Limitations of strategy and tactics without inner alignment▶ The role of psychedelics and plant medicines in transformation▶ How to recognize and shift unconscious patterns▶ The impact of energetic expansion on business and life▶ The importance of articulating your work authentically▶ The shift in the coaching industry towards deeper work▶ The split between AI-driven content and divine channeling▶ Upcoming programs for transformational growth Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz
Learn more about Parkinson's and find support: https://dpf.org Researchers are exploring a growing number of potential disease-modifying therapies for Parkinson's. But what does "disease-modifying" actually mean, and what progress is being made? In this podcast, Chris Krueger of the Davis Phinney Foundation talks with Dr. Lorraine Kalia, a neurologist and Parkinson's researcher, about the science behind disease modification and why finding therapies that change the course of Parkinson's is so challenging. Topics discussed include research targeting alpha-synuclein, inflammation, genetics, mitochondria, gene therapy, and stem cells, while also addressing common questions about experimental and unproven treatments. Dr. Kalia closes with a hopeful message: while researchers continue working toward tomorrow's breakthroughs, there are meaningful steps people with Parkinson's can take today to support their health, well-being, and quality of life. Lorraine Kalia, MD, PhD, FRCPC is a scientist at the Toronto Western Research Institute and Tanz Centre for Research in Neurodegenerative Diseases. She is also a neurologist specializing in Parkinson's disease and related movement disorders at the Toronto Western Hospital. She is an assistant professor in the Division of Neurology, Department of Medicine at the University of Toronto. Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup
Last month we kicked off the new Yoga Teacher Circle with some juicy questions about boundaries. Enjoy a teaser of that conversation. And over on Patreon I've got a bonus episode of the podcast all about a recent Shero I discovered. Enjoy!Support this show and access all the extra goodies on Patreon here: www.patreon.com/AmyMcDonaldJoin the Returning Retreat here: https://www.amymcdonald.com.au/returningJoin the Business Breakthrough Day here: https://www.amymcdonald.com.au/breakthroughAnd if you're interested in working with me individually around your own life, relationships or inner world, you can find out more about counselling here: https://www.amymcdonald.com.au/counsellingREFERENCE:Rao, Kavitha (2021) Lady Doctors: The Untold Stories of India's First Women in Medicine, Westland, Chennai
Ray Schloss: Sound as Medicine for Your Nervous System Ray brings 60+ years of life experience and a career empowering global sales teams, building community cultures, and delivering presentations that moved people to action. After 17 years at one of the world's largest software companies, he retired to found Thriving 247. During that time as a Global Director of Technical Sales, Ray hosted an internal-only podcast, interviewed senior company executives, New York Times best-selling authors, and others.Wellness has been a lifelong pursuit — deepening into a decade-plus of biohacking (including peptides like the GLPs, and hormone replacement therapy), longevity research, yoga, and meditation practices — that he's used to help people from various walks of life find deeper well-being and authenticity.Beyond coaching, Ray is a dynamic speaker, certified hypnotherapist, and professional music producer whose meditation compositions are used by the Monroe Institute, BrainTap, Roxiva, and clients worldwide.Links:https://www.thriving247.com/https://www.linkedin.com/in/ray-schloss-9491456Tagspodcast for creatives,creative podcast,podcast creator interviews,professional podcast,creative podcasts,podcast host interviews,creative podcast ideas,Bioidentical Hormone Replacement Therapy (BHRT),Holistic Wellness,Life Coach,Longevity,Men's Issues,Mindfulness & Meditation,Peptides,Relationships,Sales Expert,Sexual WellnessSupport PEG by checking out our Sponsors:Download and use Newsly for free now from www.newsly.me or from the link in the description, and use promo code “GHOST” and receive a 1-month free premium subscription.The best tool for getting podcast guests:https://podmatch.com/signup/phantomelectricghostSubscribe to our Instagram for exclusive content:https://www.instagram.com/expansive_sound_experiments/Subscribe to our YouTube https://youtube.com/@phantomelectricghost?si=rEyT56WQvDsAoRprRSShttps://anchor.fm/s/3b31908/podcast/rssSubstackhttps://substack.com/@phantomelectricghost?utm_source=edit-profile-page
Send us Fan MailWelcome to a new chapter of Delightfully Dharmic! Keilani Mason welcomes her dear friend, fellow therapist, and new co-host, Tanya Beaudoin, for a conversation about belonging, starting fresh, and finding people who make you feel more alive.From navigating marriage after military retirement to making friends as an adult, Keilani and Tanya explore the courage it takes to reach for connection. They share how small rituals can anchor us through change, why play deserves a place in everyday life, and what they love about watching their clients grow.Along the way: enthusiastic sports-mom confessions, a little Bob's Burgers energy, and a preview of their upcoming MDMA-assisted therapy training in an Italian castle—plus early hints at future men's and couples retreats.Two therapists, two messy humans, and a friendship at the heart of it all. Come laugh, reflect, and get to know your new co-host.Stay kind. Stay curious.✨ Keep the conversation going with Delightfully Dharmic. Join our community for deeper conversations, exclusive content, live gatherings & a little sacred mischief:
Song: Cycle Breakers Music by: Ríomas (with some lyric support from Yesh Salz) Notes: Ríomas gives us a conversation steeped in joy and acceptance of hard things -- in the middle of doing a hard thing, since we lost a recorded hour of our first conversation due to a tech glitch. We talk about what makes it possible to come back -- how to not get stuck -- and how that applies to breaking cycles, connecting with our ancestors of before and those to come after. I found myself inspired by their description of the culture of song circles as a way "to vision in and dream in what we're actually trying to create that's more beautiful and more free and more inclusive.” I was surprised and intrigued by their take on severance from rhythm and how regaining embodied, shared pulse is a resistance practice. Catch the whole interview to learn this song that Minnesota folk created a dance to, and hear how Ríomas found their new name and what it means! Songwriter Info: Ríomas (RiYo or Río for short, they/them), previously known as Shireen Amini, is a queer, trans masculine, Puerto Rican-Iranian artist and immigrant settler based in Portland, Oregon creating at the intersection of music, healing, and cultural change. Drawing upon pop and folk soul textures, gratefully and respectfully from Black and Afro-Latin lineages, they craft artful, participatory songs that invite realness and transformative energy. Bridging contemporary music mediums with ceremonial ways and resistance efforts, Ríomas creates soulful and joyful community singing experiences that reconnect people to their power and place. In spring 2026, they released their first community song album, Gather Your Resilience: Medicine for Liberation. Sharing Info: Yes -- The song is free to share in oral tradition contexts like song circles, but please contact me for permission and rates if interested in teaching this song as part of greater money-making ventures like multi-week choirs, workshops, classes, or performances or if interested in recording this song. Song Learning Time Stamps: Start time of teaching: 00:03:40 Start time of reprise: 01:32:12 Links: Liz Digitale Anderson: https://singingforliberation.com/ C. Onyx Li: https://www.instagram.com/pointsoflight_mu/ adrienne maree brown: Pleasure Activism: https://adriennemareebrown.net/book/pleasure-activism/ CIIS San Francisco: https://www.ciis.edu/ Plena music of Puerto Rico : https://en.wikipedia.org/wiki/Plena Vernon Bush: https://www.goodlifeproject.com/podcast/vernon-bush/ Bobby McFerrin's Circle Singing: https://circlesongs.com/ Vision fast: https://schooloflostborders.org/programs/vision-fast/ Doesn't Mean by Ríomas ABS Episode 249: https://www.abreathofsong.com/p/249-doesnt-mean Mountain Song, Te Martin: https://www.lamafoundation.org/mountain-song/ Tracy Robertson: https://www.instagram.com/tracyljrobertson/?hl=en Sarina Partridge, “I Am of This Earth”: https://sarinapartridge.bandcamp.com/track/of-this-earth Dark as Night by Nahko And Medicine For The People: https://www.nahko.com/music Persian Aush soup – a Samin Nosrat recipe is behind a NYTimes paywall, so here's another one!: https://www.101cookbooks.com/new-year-noodle-soup/ Los Pleneros de la Cresta: https://losplenerosdelacresta.com/ Riomas's recent album, “Gather Your Resilience,” on Bandcamp: https://riomas.bandcamp.com/album/gather-your-resilience-medicine-for-liberation Patreon: https://patreon.com/riomas Instagram: @riomasmusic Linktree: https://linktr.ee/riomas Artist Website: https://shireenamini.com/ Music as Medicine: https://shireenaminimusicmedicine.com/ Nuts & Bolts: 2:2, minor, harmonizable song form Join this community of people who love to use song to help navigate life? Absolutely: https://dashboard.mailerlite.com/forms/335811/81227018071442567/share Help us keep going: reviews, comments, encouragement, plus contributions... we float on your support. https://www.abreathofsong.com/gratitude-jar.html
Scientific Sense ® by Gill Eapen: Prof. Robert Lustig who is Professor Emeritus of Pediatrics at the University of California, San Francisco, and the Director of the Weight Assessment for Teen and Child Health (WATCH) Program at UCSF. His most recent book is Metabolical – The Lure and Lies of Processed Food, Nutrition and Modern Medicine.Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1
Turkish researchers discovered that WiFi-frequency radiation exposure during pregnancy caused thyroid damage in offspring that persisted for an entire year after birth -- suggesting the effects may last a lifetime. In this episode, I break down a troubling new study from Electromagnetic Biology and Medicine that examined rat offspring one year after their mothers were exposed to two point four five gigahertz radiation during pregnancy. The findings reveal significant structural changes, increased cell death, and DNA damage in the thyroid glands of exposed animals -- all from prenatal exposure alone. In This Episode Why thyroid health during pregnancy matters more than most people realize What researchers found when they examined thyroid tissue one year after prenatal WiFi exposure The specific biological changes that signal long-term damage One practical step pregnant women can take today to reduce exposure Featured Study Read the full study: One-year follow-up of thyroid status in rats exposed to 2.45 Ghz radiofrequency radiation during the prenatal period See all studies at shieldyourbody.com/research
One in four patients currently being considered for life support withdrawal may actually be fully conscious, they just can't signal it. That single finding, from a landmark New England Journal of Medicine study, is the practical stakes behind one of the most philosophically rich conversations in this series. Dr. Christof Koch - former president of the Allen Institute for Brain Science, 25-year collaborator with Nobel laureate Francis Crick, and founder of the startup Intrinsic Powers - joins Craig Smith to discuss why the hard problem of consciousness remains unsolved, what integrated information theory predicts about which systems can and cannot be conscious, and why his own mystical experience three years ago shifted his view from physicalism toward idealism. The conversation is grounded throughout in empirical work: Koch explains how Intrinsic Powers uses brain complexity measurements - sending magnetic pulses into the brain and measuring the complexity of the electrical response - to detect consciousness in behaviorally unresponsive patients, providing clinical teams and families with one critical bit of information at the most consequential moment of their lives. The episode closes with Koch's most personal revelation: a mystical experience in which the boundary between self and world dissolved and he felt direct acquaintance with the idea that everything is ultimately mental, an experience he is careful to distinguish from supernatural claims, but which shifted his metaphysical view in ways he describes with unusual candor for a scientist of his standing. Subscribe to Eye on A.I. for weekly conversations with the people building and deploying the future of AI.
The CEO of the AARP is on a mission to have all of us recognize that people over 50 are an economic force. Their households account for 56 cents of every dollar spent in this country. Workers over 50 make up more than 40% of the workforce. Dr. Myechia Minter-Jordan joins Cladia to talk about what America would look like if our culture, workplaces, products, infrastructure and policies actually reflected this reality.Claudia and Myechia cover: Why caregiving has to move from a private family burden to a public policy priorityWhat innovators get wrong about older adultsHow closing the 12.5-year gap between lifespan and healthspan could reshape what we build, fund and prioritizeDr. Minter-Jordan says there is an economic and business rationale for moving to a longevity economy: “Our demographics are changing, people are living longer, they're staying in the workplace longer, there are now five generations in the workplace. So all of these pieces together have created the urgency for us to think differently about aging. “Relevant LinksGet more information about joining AARPFind more details on the AARP Community Challenge Grant ProgramRead the Credit for Caring Act Dr. Minter-Jordan mentionedAbout Our GuestAs CEO of AARP, Dr. Myechia Minter-Jordan leads the world's largest nonprofit, nonpartisan membership organization, harnessing the power and passion of almost 2,300 staff members, 60,000 volunteers, and numerous strategic partners. Dr. Minter-Jordan, who was named CEO in November 2024, is an accomplished physician, passionate advocate, and innovative leader who deftly merges a passion for social impact with the business acumen to make strategic decisions, foster meaningful collaboration across engaged teams, and successfully lead organizations through periods of rapid change and growth. Throughout her career, she has fought to shine a national spotlight on the importance of social equity and the far-reaching impact of philanthropy and giving back. After a successful early career in academic medicine at Johns Hopkins, where she was an attending physician and instructor, she was inspired to serve as Chief Medical Officer and ultimately President and CEO of the Dimock Center, one of the largest community health centers in Massachusetts.Dr. Minter-Jordan's journey to transform the health care industry continued at the CareQuest Institute for Oral Health in Charlestown, Massachusetts, where she served as President and CEO from 2020 until 2024.Dr. Minter-Jordan has consistently prioritized giving back through her service on a wide range of boards and commissions, including BlueShield of California, Yawkey Foundation, Point 32 Health, and The Boston Foundation. She has received numerous awards for her contributions, including Harvard Medical School's Reede Scholar Vision Award and the Terrance Keenan Leadership Award in Health Philanthropy from Grantmakers in Health.Dr. Minter-Jordan is a graduate of Brown University and earned her MD from the Brown University School of Medicine and her MBA from the Carey School of Business at Johns Hopkins University. She holds an Honorary Doctor of Public Service degree from Northeastern University and an Honorary Doctorate of Humane Letters from Newbury College.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!
This episode is sponsored by NURP NURP helps busy physicians grow their wealth through AI-powered algorithmic trading designed for demanding careers. No day trading, no guesswork, and no constant market watching required. Ready to put your money to work? Visit start.nurp.com/doctors to learn more. Trading involves risk, and results may vary. This is not financial advice. —---------------------------- What would make a doctor walk away from pathology residency just one year from finishing? In this inspiring episode of BootstrapMD, host Dr. Mike Woo-Ming welcomes Jackie Dallas: physician by training, actress by passion, and women's health advocate. She explains how she treated acting as a business rather than waiting to be discovered, leveraged her real medical background to book early roles, and navigated early typecasting as an Asian actress. Listeners hear the story behind her breakout role in Stranger Things Season 1 and her recurring role in the Netflix hit The Hunting Wives. Jackie also discusses her return to medicine through advocacy, launching HerHealth101.com to educate women about underdiagnosed pelvic floor conditions, self-advocacy in short appointments, and the ongoing underfunding of women's health research. She closes with practical advice for physicians curious about creative careers: start small, treat it like a business, and don't quit your day job until you've tested the waters. Three Actionable Takeaways: The sunk-cost fallacy keeps many physicians stuck; Jackie left with one year of residency remaining because she knew the path wasn't right for her. Acting is a business, not magic: Treat it like any other career; build credits, develop skills, get representation, and persist through rejection. Physicians have unique advantages in creative fields: (authenticity in medical roles, research skills, discipline). Jackie now channels that same training into women's health education via HerHealth101. About the Show: Bootstrap MD is the ultimate podcast for physician entrepreneurs looking to escape traditional healthcare and control their financial futures. Hosted by Dr. Mike Woo-Ming, a successful physician, entrepreneur, and investor, the show delivers actionable insights on starting businesses, creating passive income, and navigating healthcare entrepreneurship. Featuring interviews with industry leaders, physicians, and experts in telemedicine and digital health, it's your guide to building a profitable, fulfilling career. Tune in weekly at http://bootstrapmd.com About the Guest Jackie Dallas is a SAG-AFTRA actress and former physician. She trained in surgery and pathology before leaving medicine to pursue acting full-time. Her credits include Stranger Things (Season 1), 13 Reasons Why, Magnum P.I., NCIS: Hawai'i, Criminal Minds, Fear the Walking Dead, and a recurring role as a political strategist in Netflix's The Hunting Wives. She is the founder of HerHealth101, a platform dedicated to educating women about pelvic floor health and self-advocacy. Connect with Jackie Dallas: Website: https://www.jackiedallas.comHerHealth101: https://herhealth101.comInstagram: @jaxdallasIMDb: imdb.me/jackiedallas About the Host: Dr. Mike Woo-Ming has over 20 years of experience as a physician entrepreneur. He's built and sold multiple seven-figure companies and now leads Executive Medical, a group of clinics specializing in age management and aesthetics. Through BootstrapMD, he mentors physicians in business, content creation, and autonomy. Let's Connect: www.https://www.bootstrapmd.com Want to start a podcast? Check out the Doctor Podcast Network! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In today's episode, we spoke with Jacqueline Aredo, MD, and Benjamin Bleiberg, MD. Dr Aredo is a thoracic oncologist at Mass General Brigham Cancer Institute in Boston, Massachusetts, and Dr Bleiberg is an adjunct assistant professor of medicine at the University of Pennsylvania Perelman School of Medicine in Philadelphia.In our exclusive interview, Drs Aredo and Bleiberg reflected on the experiences and relationships that shaped their transitions from fellowship into their first faculty positions in thoracic oncology and on the role that smaller, specialty-focused meetings played in building the professional community that supported them along the way.Both physicians spoke to the value of the ASCO Fellows Forum, a one-day event held annually before the ASCO Annual Meeting, describing it as a low-stakes, high-value environment where fellows present research abstracts in small groups alongside peers from other institutions and senior mentors. They noted that beyond the opportunity to practice presentation skills and refine research projects, the forum serves as a catalyst for organic relationships that have extended well beyond the event itself. Dr Bleiberg noted that many of the colleagues he met through programs like this, individuals with shared research interests at the same career stage, became lasting professional connections he would not have encountered otherwise. Dr Aredo added that these forums created direct pathways to mentors at institutions she was actively exploring for her job search, with several going on to advocate for her and connect her with senior investigators in her area of focus.The discussion then broadened to the fellowship-to-faculty transition itself. Both physicians emphasized the importance of identifying priorities early and being transparent about those priorities throughout the interview process. Dr Aredo noted that the more non-negotiable parameters a fellow has, the narrower but clearer the search becomes. Dr Bleiberg highlighted the value of speaking candidly with junior faculty at prospective institutions to get an unfiltered view of institutional culture, and of presenting one's goals honestly so that the position that results is a genuine fit.Both physicians also acknowledged that the job search timeline is far more asynchronous than prior training milestones like the match, with opportunities presenting themselves on different schedules from different institutions. They encouraged current fellows not to be discouraged by the pace or uncertainty of the process, and advised having a polished CV and cover letter ready sooner than expected. Leaning on internal mentors, external advocates, and co-fellows were cited as essential strategies for navigating what both described as a marathon rather than a sprint.Finally, Drs Aredo and Bleiberg underscored that in a field where the world grows smaller the further along one progresses, investing early in community-building at specialty meetings pays dividends well beyond any single conference. Knowing one's research identity, following up on relationships consistently, and recognizing that today's co-fellows are tomorrow's collaborators and references were offered as the most lasting lessons from their own transitions into faculty life.
Pregnancy can bring major changes to digestion and bowel habits. But if you're already living with irritable bowel syndrome with constipation (IBS-C), bloating, abdominal discomfort, or chronic constipation, it can be difficult to know what's related to pregnancy—and what may be related to your digestive condition. In this episode of the Gastro Girl Health Podcast, Dr. Lin Chang, Professor of Medicine at the David Geffen School of Medicine at UCLA and a leading expert in disorders of gut-brain interaction and women's digestive health, explains what patients should know about IBS-C and constipation during pregnancy. You'll learn: • How pregnancy-related constipation differs from IBS-C • Why IBS symptoms may change during pregnancy • What may contribute to increased bloating and constipation • Diet and lifestyle strategies to discuss with your healthcare provider • What to know about the low-FODMAP diet during pregnancy • Treatment and medication considerations • Symptoms that shouldn't automatically be attributed to IBS or pregnancy If you're pregnant—or planning a pregnancy—and live with IBS-C or chronic constipation, this conversation can help you better understand your symptoms and prepare for conversations with your healthcare team. This patient education episode was produced by Gastro Girl in collaboration with the American College of Gastroenterology Patient Care Committee. #IBSC #Pregnancy #Constipation #IBS #Bloating #DigestiveHealth
In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Noah A. Kolb, MD, who served as the guest editor of the October 2026 Peripheral Nerve and Motor Neuron Disorders issue. They provide a preview of the issue, which publishes on October 2, 2026. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Kolb is a professor of neurological sciences at the Robert Larner College of Medicine at the University of Vermont in Burlington, Vermont. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Full episode transcript available here Dr. Jones: The human brain is incredibly complex. That's one of the reasons we like to study it and care for patients with neurologic problems. But to translate cognition into action, we need a functioning sensorimotor and autonomic peripheral nervous system. What do we do when those peripheral systems aren't working? Today, we're speaking with Dr. Noah Kolb, guest editor of our latest issue of Continuum on peripheral nerve and motor neuron disorders. Dr. Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast. Dr. Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr. Noah Kolb, who is Continuum's guest editor for our latest issue on peripheral nerve and motor neuron disorders. Dr. Kolb is a professor of neurology at the University of Vermont Larner College of Medicine in Burlington, Vermont, where he specializes in the care of patients with neuromuscular disorders, including patients with peripheral neuropathy and other immune-mediated neuromuscular diseases. Dr. Kolb, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners? Dr. Kolb: Well, thank you very much for having me. Please call me Noah. I've been a longtime listener of Continuum, dating all the way back to when they came on CDs, so it's really a pleasure to be here. Like you said, I'm a neuromuscular doctor up in Vermont. I take care of the whole scope of neuromuscular disease, but kind of wear 3 different hats. I focus my research primarily in chemotherapy-induced neuropathy, but also do other diseases as well. Obviously, see patients clinically, and then I'm an educator as well, so I run the neurology clerkship and the acting AIs for the medical school. So, it's a fun job. Dr. Jones: Well, thanks for sharing that little bit of history on Continuum Audio, Noah. I got to be honest with you, I don't know if I've ever seen a Continuum Audio CD. If anybody out there in the audience has a Continuum Audio CD, post a picture online and we'll like and share it. I wonder how many of those are still out there. I really appreciate you not just joining us today, Noah, but also putting together this really stellar issue, a very timely update and overview of peripheral nerve and motor neuron disorders. A lot of good topics for us to dig into today. What I'm going to do before we get into questions is ask our audience Continuum Audio's trivia question. Dr. Kolb and I were talking about this before we started recording here. So, the trivia question, just to frame it up a little bit, the transthyretin or TTR protein receives a lot of attention in neuromuscular medicine as the protein behind the most common causes of acquired and familial amyloidosis. But transthyretin is known in clinical settings by a different name and checked for an entirely different reason. So, the trivia question is, what is the other common name for transthyretin? Stick around, and we'll share the answer at the end of our interview. So, let's get right to it. Our listeners know that peripheral neuropathy is common, right? It affects 2 to 3 percent of the general population and 6 to 7 percent of patients who are older than 60. In your mind, Noah, what's the main thing you would like clinicians to know or do differently in the care of these patients? Dr. Kolb: Yeah, that's a great question. I think it's something that we spend a lot of time teaching our residents and working with our fellows about is understanding the right workup for people presenting with neuropathy because it's very easy to overdo it with more labs and a broader workup than you need. So, when somebody presents with sort of a garden variety neuropathy that doesn't have red flags, the important things to order in terms of a workup are hemoglobin A1C, B12, and SPEP with IFE, potentially serum light chains, and some thyroid studies as well. Because those are really the most common reasons, and then to make sure that they ask the most important historical questions, like about alcohol use, et cetera. If you're going to find a cause for neuropathy, particularly if it's slowly progressive and sensory predominant, oftentimes the answer is found right in that basic workup. Dr. Jones: Got it. And I think that's very well taken. And I think one of the questions that commonly comes up in the neuromuscular, but also in the broader neurology setting is, when you're evaluating a patient, especially an older patient who has a new onset length-dependent sensorimotor peripheral neuropathy, you've identified the neuropathy, and you're starting to consider what are those potential underlying disorders or risk factors that that neuropathy could be a warning sign of, right? So, you look for metabolic disease, B12 deficiency, paraproteinemia, et cetera. Where do you stop? In what settings do you do more expanded evaluations, genetic testing, et cetera? Dr. Kolb: Yeah, and I think this kind of goes back a little bit to the last question where the primary focus of the workup that we do is driven by the most common causes. That's why hemoglobin A1C is so important. And so, thinking through what is likely to be the cause in the specific patient setting is kind of really critical. And again, if you don't have red flags, then the labs that we mentioned previously are probably sufficient in terms of a workup. But if there are any of the other red flags, it's really important specifically because there may be treatable causes of neuropathy or things that would affect the prognosis that'd be important to understand earlier so we can make sure we either engage the right therapies or do a broader diagnostic workup. An important part of that is understanding when to use EMG nerve conduction studies and when not to. So obviously, as a neuromuscular doc who does EMGs, I'm very fond of them. But we regularly see patients in our lab who perhaps don't need one. If somebody has a sensory predominant, slowly progressive neuropathy, particularly if you have an etiology, those patients usually don't need an EMG nerve conduction study. When it's asymmetric, when there's prominent weakness, when there's a lot of autonomic symptoms, those are the times when it can be a lot more informative and helpful to try to get an EMG nerve conduction study to see if we can get at what the underlying etiology is. Dr. Jones: That's very helpful, Noah. Thank you. And so, let's think about a scenario that I think many of our listeners may have encountered in their practice. You're seeing a patient who has a somewhat rapidly progressive, painful neuropathy, which has some small fiber characteristics. They've got a little bit of autonomic dysfunction, and you worry about the possibility of amyloidosis. How do you approach that evaluation and treatment, and why is it important to think about that diagnosis? Dr. Kolb: Yeah, that's great. It's important to think about that diagnosis because we now have good treatments for AL amyloid and for ATTR-based amyloid. So, because these are treatable disorders, it's really critical that you identify them. And the reality is it's not always straightforward making a diagnosis of amyloid. As you would with any other type of neuropathy, the workup is gonna begin with serum free light chains, SPEP, trying to see if there are any monoclonal gammopathies or elevation in light chains. But importantly, you need to think about what the next diagnostic steps are and understanding how likely those tests are to be abnormal in the setting of amyloid is important as well, because the easier to obtain tests don't have perfect sensitivity. So, once you've moved on kind of from the basic labs, we think about a fat aspirate or a skin biopsy to look and see if there's any evidence of amyloid. But if your clinical suspicion is high enough, it's important to move to a sural nerve biopsy and genetic testing. That's really the best way to confirm this diagnosis. Dr. Jones: Very helpful. And obviously, that's not just academic, as it might have been at one point. This is something that we now have good disease-modifying therapies for, which leads to another question that I think our listeners may encounter in their practice. When you think about all the available gene tests in panels and other genomic tools that we have to investigate patients, when do you do a broad genetic evaluation for patients with neuropathy? Dr. Kolb: Yeah, it's a good question. It depends partly on specifically what we're looking for. I think that as with many things in neurology, one of the reasons I got interested in it, and many people did, is we like doing detective work, and the history often lies in the examination and in our clinical history at the bedside. And for that reason, often just in getting the initial history with a patient, you start to get clues that there may be a hereditary component. Sometimes it's in the history where you're able to elicit a family history of disorder, and they may or may not know that the patient had neuropathy, but it may be that somebody walked funny later in life or somebody always complained of foot pain. Or it may simply be when a patient takes their shoes off, or in Vermont, they're wearing sandals, and you see that they have characteristic changes of a neuropathy that is much more longstanding than the patient even recognizes. That's often the case with some of these forms of hereditary neuropathy because sometimes they don't have a lot of pain. And so, you see those characteristic changes in the foot, and it cues you to the need for genetic testing. In my world where I see a lot of patients with chemotherapy-induced neuropathy, I also think about it in patients who seem to be specifically sensitive to neurotoxic agents, where they get a much worse neuropathy than you would expect with exposure to drug, and it's important to consider it in those times as well. Dr. Jones: That's a great framing. I appreciate the way you put that. One of the great points in the issue is that patients who have sensory findings out of proportion to their sensory complaints, a lot of times it's worth thinking about a familial or genetic mechanism and then digging a little more into that family history, right? Dr. Kolb: I agree. Dr. Jones: Yeah. So, let's think of a different scenario. I know you do a lot of work with immune-mediated acquired neuropathies, and we're fortunate now, obviously, we have a lot of immunotherapy tools for the treatment of patients with neuropathies like chronic inflammatory demyelinating polyradiculoneuropathy. When it comes to CIDP, Noah, what's your initial approach to immunotherapy? That's one question. And another is, how do you incorporate some of the newer agents like efgartigimod? What's the role of that drug, or when do you go to rituximab or rozanolixizumab? Walk us through your approach to that. Dr. Kolb: Yeah, so I think it depends a lot on what the clinical presentation looks like and kind of what the patient's preference is. In taking care of neuropathy patients for what's been quite a while now, you find that some patients have a differing comfort level with sort of the newer drugs like efgartigimod versus some of the therapies that have been around for years and years and are tried and true. So, we know, for instance, that plasmapheresis and IVIG work well. In certain cases, we use steroids because they can work well as well, but also have long-term toxicities that you want to be aware of. It's been really exciting to see that efgartigimod is a new therapy that's on the market, and it's been a really interesting space to be involved in, in neuromuscular medicine as some of these new disease-modifying therapies have come out. The trials for efgartigimod are really exciting, and it was very important to our field when efgartigimod became available. But there have been other trials that showed similar drugs weren't that effective, and there are many studies happening right now for complement inhibition with varying results. So, it's been sort of one of these hot topics in neuromuscular medicine, trying to see what these new therapies are and figuring out how to integrate them. I find that oftentimes with patients, we'll start with the tried and true therapies like IVIG or plasmapheresis, but don't hesitate to reach to efgartigimod, particularly if it's more convenient for the patient. I think the other important point to make, and this is addressed nicely throughout some of the manuscripts, is that there are specific instances where certain drugs are preferred. So, for instance, if you're seeing somebody with CIDP that has hard-to-treat symptoms, is not responding to the normal therapies that we use, it's important to think about whether they may have a paranodal form of CIDP, in which case we often reach for things like rituximab instead because it works better. Dr. Jones: Outstanding. And so, I think that speaks to the importance of phenotyping, right? As we learn more about these acquired immune-mediated neuropathies, we're splitting, right? We're finding that the mechanisms are different in the tools that we have, the treatments are going to be more tailored, and more personalized to the patient. I think that's a great takeaway from the issue. So, Noah, you're in a unique position here, right? You're a world-renowned neuromuscular expert, and you have just edited a bunch of articles on neuromuscular medicine, peripheral nerve, motor neuron disorders written by experts in their respective fields. So, you have this bird's eye view of the specialty up to the minute, what's the latest. When you think about the entire issue, what would you say is the one topic that our readers or listeners could go to, to close the most important education gap in neuromuscular medicine? Dr. Kolb: It's a great question. It's akin to asking who my favorite child is, of which is all of them, but I would say that when Amro Estino and Ben Becker submitted their manuscript on paraproteinemic neuropathies, after I read it, I wrote an email back to them just telling them how well I thought it was organized and that it really addressed an issue that constantly plagues trainees and practitioners, is how to deal with monoclonal gammopathies and paraproteinemic neuropathies. It's a nice example of what happens when you give smart people the creative space to organize something in a way that they think makes sense. I certainly learned about the topic reading that, and I think it'd be very high yield for people reading Continuum. Dr. Jones: Totally agree. It's a wonderful article among many great articles, and that is a persistent education gap. So, I would direct our listeners to that article as well. You know, one of the things that I think about, you're an educator, I'm a clinician educator myself, thinking about the really interesting world of neuromuscular medicine, right? I have a significant part of my practice is in neuromuscular medicine and EMG, and I enjoy that very much. What do you think about trainees who might be interested in neuromuscular medicine, and they want to focus in it or pursue it as a career? How should they approach it? What does the training landscape look like from your perspective? Dr. Kolb: Yeah, that's a great question and an important one. So, I think that the case to be made for neuromuscular medicine is strong. I talk with the residents and my medical students about this regularly, but I think it's hard to find a place in medicine where the field is evolving more rapidly than it is in neuromuscular medicine, which makes it sometimes hard to stay up to date with everything that's happening, but it also makes it really interesting. To have new medicines coming online for us to change the paradigm for the way we've been treating patients for years and years is very exciting, and I think that those changes are only going to grow. Part of the future of neuromuscular medicine really is going to be in better genetic testing and broader genetic therapies. When you think about hereditary neuropathy as an example, there are tons of emerging therapies that are in pre-clinical trials and some starting in clinical trials. And so, the future of neuromuscular medicine is going to be constantly evolving where we can now treat disorders that we couldn't treat before. I mean, the easiest example is SMA, where previously that was a universally fatal disease for infants, right? And now we have treatments that are very effective. And there are multiple diseases where we're starting to develop therapies like this, so it's really exciting. From a training perspective, there are lots of opportunities for residents as they approach fellowship. There are tons of great neuromuscular fellowships around the program. I would include UVM in there as well, where there's really a wide variety of neuromuscular things that you can learn. And it's a wide and varied field, so people are learning ultrasound, which has been an emerging part of neuromuscular medicine, EMG, electrodiagnostics, Botox, but then also treating autoimmune disorders, hereditary disorders. So, it's really quite a broad field, and you can really sort of super sub-specialize into different areas, which allows you to really focus if that's what you want to do. Dr. Jones: So now it's time for the answer to our Continuum Audio Trivia question. Just to remind our listeners, what is the other common name for transthyretin? We think about transthyretin a lot, as Noah mentioned, in terms of acquired and familial amyloidosis, but what is the other name for it? Dr. Kolb, do you want to give the answer to our audience? Dr. Kolb: That would be prealbumin. Dr. Jones: Prealbumin. Again, we talk about transthyretin all the time because of the neurologic and cardiac presentations of ATTR wild type and variant transthyretin amyloidosis. But the protein itself, in the non-pathologic setting, in the non-amyloid setting, is a stable tetramer. Its normal function is to transport thyroxine and vitamin A throughout the body, but it also has a relatively short half-life. And on electrophoretic gels, it segregates near the albumin band, and therefore, for a long time was just called prealbumin because it was near the albumin band. And because of that short half-life, it's used as a rough or loose marker of nutritional status. So, all those times when I was a medical student and a resident ordering prealbumin to assess nutritional status, I was really checking transthyretin, and I had no idea. Dr. Jones: All right. So, Dr. Kolb, I really want to thank you for joining us. Thank you for such an outstanding conversation about peripheral nerve and motor neuron disease in the latest issue of Continuum. I learned a lot reading this issue. I learned a lot in our conversation today. I hope our listeners did too. I'm really grateful for your hard work taking on this issue, which I think will come in handy not only to our more junior listeners and subscribers, but also, our more experienced listeners as well. Dr. Kolb: Thanks for the opportunity to chat with you. I'm excited for the public to see the Continuum manuscripts. I think there's a lot to learn, and it's an exciting issue. Dr. Jones: I agree. Again, today we've been speaking with Dr. Noah Kolb, guest editor of Continuum's most recent issue on peripheral nerve and motor neuron disorders. Please check it out, and thank you to our listeners for joining today. Dr. Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.
Two of the most widely used chemotherapy drugs in the world, 5-FU and capecitabine, have been in use since the 1950s. A small share of patients carry variants in a gene called DPYD that slow their ability to break these drugs down, which means a standard dose behaves like an overdose in their body.A single genetic test can identify those patients before the first treatment. Europe recommended universal screening in 2020. The FDA updated the labels for both drugs in 2025, after years of pressure from families who had lost someone.In this episode of Patient From Hell, host Samira Daswani speaks with Dr. Gabe Brooks, a medical oncologist at the Dartmouth Cancer Center, about what DPD deficiency is, what severe toxicity actually looks like, how and when to get screened, what the test costs, and the exact question to ask before starting either drug.Guest: Gabriel Brooks, MD, MPH, is a medical oncologist and Associate Professor of Medicine at the Dartmouth Cancer Center and the Geisel School of Medicine. He co-directs the Cancer Population Sciences Research Program and specializes in gastrointestinal cancers, including colorectal cancer.Chapters00:00 Introduction00:27 What DPYD is and why it matters02:50 When toxicity turns fatal04:21 5-FU vs. capecitabine06:16 Which cancers use these drugs06:53 What the FDA changed08:26 Why the U.S. took five years longer than Europe11:27 Warning signs and time to onset15:28 How and when to get screened17:39 Germline DNA vs. tumor genomic testing20:16 The patient advocacy behind the change24:44 What to ask your oncologist26:43 What the test costs28:18 Closing thoughtsResources: Advocates for Universal DPD/DPYD Testing — test4dpd.org
Plus: Several events are being held across Canada as the country remembers its residential school legacy and honours survivors and victims, mid-term elections are right around the corner for the U.S. as Carney says he won't apply new trade pressure right now, more U.S. troops are leaving Iraq, and a new survey finds young Canadians are growing more and more skeptical of democracy in this country. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca Or @thebigstory.bsky.social on Bluesky Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
What happens when mothers, homeopathy, and powerful stories come together? In this episode of the Intuitive Homeopathy Podcast, Angelica sits down with filmmaker David Neptune to discuss Mother Medicine, an inspiring documentary premiering October 14th in Santa Monica.David shares his journey into filmmaking and the unexpected story behind Mother Medicine, born from a women's retreat centered on healing and empowering mothers. They explore intuition, vulnerability, healing, and the powerful experiences of mothers raising sick children.
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this special episode of Mind Moments, released in recognition of Limb-Girdle Muscular Dystrophy (LGMD) Awareness Day on September 30, Katherine Mathews, MD, professor of pediatrics and neurology at the University of Iowa Carver College of Medicine, joins the podcast to discuss the evolving treatment landscape for LGMD and the potential significance of BBP-418, an investigational oral therapy for LGMD2I/R9.With an FDA decision expected by November 27, 2026, BBP-418 could become the first approved therapy for LGMD2I/R9 and potentially the first treatment approved for any form of LGMD. Mathews breaks down the therapy's FKRP-targeted mechanism, findings from the phase 3 FORTIFY study, and the challenges of conducting clinical trials across genetically diverse and slowly progressive forms of LGMD. She also discusses what a first approval could mean for the broader LGMD community, considerations for bringing patients back into specialty care, and research priorities that could accelerate development of future therapies.Looking for more Neuromuscular discussion? Check out the NeurologyLive® Neuromuscular clinical focus page.Episode Breakdown: 1:15 – BBP-418's mechanism and therapeutic rationale for FKRP-related LGMD2I/R9 4:00 – FORTIFY findings supporting BBP-418's potential effects on muscle and pulmonary function 7:50 – Why genetic heterogeneity and slow progression complicate LGMD clinical trials 10:10 – Neurology News Minute 12:45– What a first FDA-approved LGMD therapy could mean for patients and clinicians 15:40 – Research priorities for accelerating clinical trials and developing future LGMD therapies The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: CHMP Recommends EU Approval for Ocrelizumab in Pediatric Relapsing MS SKY-0515 Shows Sustained Benefit at 15 Months in Huntington Disease FDA Approves Tavapadon for the Treatment of Parkinson Disease Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
About the Speaker:Dr. Rene Amaya earned his medical degree from UT Southwestern Medical School in Dallas and completed his residency in pediatrics at Phoenix Children's Hospital/Maricopa Medical Center in Phoenix. He completed his fellowship in pediatric infectious diseases at Texas Children's Hospital/Baylor College of Medicine in Houston.Board-certified in pediatric infectious diseases by the American Board of Pediatrics, Dr. Amaya expanded his scope of practice in 2013 to include pediatric wound care. He currently provides hospital-based consultations in both pediatric infectious diseases and pediatric wound care across five hospitals in the Houston area. He currently serves as Director of Infectious Disease and Wound Care for the Pediatrix Medical Group, Gulf Coast Division.Dr. Amaya is a Board Member of the International Society for Pediatric Wound Care. Much of his research focuses on neonatal wounds. He has authored numerous scientific abstracts, peer-reviewed journal articles, and textbook chapters, including contributions to both editions of Neonatal and Pediatric Wound Care textbooks. He is a frequent speaker at national and international wound care conferences and seminars. Outside of medicine, Dr. Amaya maintains a balanced lifestyle through yoga, Pilates, and swimming. He is also a certified yoga instructor. Editing and post-production work for this episode was provided by The Podcast Consultant.
On this episode of Be the One, we sit down with two Brookstone seniors, Brennan and Lucy Bell, to talk about their summer as Swift Scholars.Lucy spent three weeks at Brown University in an intensive drawing program, working with charcoal, graphite, and ink, and learning what college-level critiques really feel like. Brennan headed to Duke for a pre-college Introduction to Medicine program, where his group's capstone project took on the youth vaping epidemic. Somehow he also fit in one of the biggest baseball summers of his life, with stops at the Perfect Game and Under Armour All-American games.They also talk about how they found Brookstone in the first place (shoutout to the tour guides), the freshman retreat, the quad, bonfire night, favorite cafeteria meals, and the teachers who've made the biggest difference for them.
You have a promising technology – but does that mean you should build a company around it?In the second installment of our listener-submitted questions series, producer Ian McLachlan is back in the host seat with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, to tackle questions about starting and building a biotech company. They explore one of the most important lessons for aspiring founders: fall in love with the problem, not your solution, and make sure there is a real customer willing to change what they are doing and pay for something better.In this episode, you'll discover:How to determine whether a technology solves a meaningful problem, has a real market, and should become a company in the first place.Why customer discovery should begin before you build the company and how early conversations with customers, investors, and partners can test your assumptions and strengthen your strategy.How founders can establish milestones and go/no-go decisions that help them recognize when to move forward, pivot, or shut a company down before wasting valuable time and capital.Starting a biotech company is hard, but for founders with the right problem, the right team, and the passion to keep going, the potential impact can make the risk worthwhile. Tune in for a candid look at what aspiring entrepreneurs should consider before turning an idea into their next company.Links:Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine. Learn about NSF I-Corps and I-Corps at NIH.Check out Elaine's book recommendations: The Lean Startup, The Startup Owner's Manual, Business Model Generation, and Talking to Humans.Connect with Haley Marcotte and learn about Nucleate New Orleans.Connect with Ian McLachlan, BIO from the BAYOU producer, and submit your questions for future episodes!Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
More than half of people living with HIV in the U.S. are over the age of 50, and within a few years it will likely be more than two thirds, if we're not there already. You probably already know first-hand the challenges of adapting and evolving care to meet the needs of a patient population that is older than we envisioned back when we formed a lot of the HIV care systems we now rely on. This month, Meredith Greene, M.D., joins us to talk about that adaptation and evolution by discussing her path to becoming a leading HIV specialist and geriatrician, her experience creating the distinguished Golden Compass clinic in San Francisco, and her efforts to apply that knowledge and experience in her current role as an associate professor of medicine at the Indiana University School of Medicine and a scientist at the Center for Aging Research. Support the podcast by visiting the transcript, which includes a summary of key points and additional resource links: https://www.thebodypro.com/podcast/hiv/future-hiv-care-meredith-greene-aging-geriatric-clinic-sept-2026 The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Thanks this month to our contributing editor Roger Pebody for his background research and interview prep assistance.
All Home Care Matters and our host, Lance A. Slatton, were honored to welcome Dr. Hussen Amen, board-certified family medicine physician and founder of Amen Family Medicine, as a guest to the show. In this important conversation, Dr. Amen joins Lance to discuss the role proactive primary care can play in helping older adults maintain their health, independence, and quality of life while safely aging in place. The discussion explores the Medicare Annual Wellness Visit and why it is different from a traditional physical, as well as some of the important health concerns primary care physicians look for as patients age. Dr. Amen shares valuable insight into fall prevention, changes in mobility, memory and cognitive concerns, medication management and polypharmacy, preventive screenings, nutrition, advance care planning, and the importance of identifying subtle health changes before they develop into a medical crisis. Lance and Dr. Amen also discuss the important role family caregivers can play as part of a loved one's healthcare team and why establishing a strong relationship with a trusted primary care physician before a crisis occurs can make a meaningful difference. For older adults and their families, proactive healthcare is about more than treating illness. It is about prevention, early detection, communication, and helping individuals remain as healthy and independent as possible. About Dr. Hussen Amen: Dr. Hussen Amen is a board-certified family medicine physician and the founder of Amen Family Medicine, an independent primary care practice in Livonia, Michigan. A Metro Detroit native who grew up in Dearborn, Dr. Amen earned his bachelor's degree in Nutrition and Food Science from Wayne State University before receiving his medical degree from St. George's University School of Medicine. He completed his Family Medicine residency at Trinity Health Livonia, where he continues to maintain hospital privileges. Living with Type 1 diabetes since childhood has given Dr. Amen a unique perspective on the patient experience and the importance of preventive, relationship-centered care. His clinical interests include preventive medicine, chronic disease management, sports medicine, and point-of-care ultrasound. He is passionate about helping patients stay healthy, maintain their independence, and avoid preventable hospitalizations through proactive primary care and patient education. About Amen Family Medicine: Amen Family Medicine is an independent primary care practice located in Livonia, Michigan, founded by Dr. Hussen Amen with the mission of providing personalized, relationship-centered healthcare for patients of all ages. As a privately owned practice, Amen Family Medicine focuses on building lasting relationships with patients while delivering accessible, evidence-based care tailored to each individual's needs. The practice offers comprehensive family medicine services including preventive care, annual wellness visits, chronic disease management, same-day sick visits, women's health, pediatric care, sports medicine, and minor office procedures. Amen Family Medicine also provides in-office digital X-ray, point-of-care ultrasound, laboratory services, EKGs, and ultrasound-guided procedures, allowing many conditions to be evaluated and treated conveniently under one roof. For older adults, the practice emphasizes preventive care, medication management, fall prevention, cognitive screening, and coordination with caregivers and specialists to help patients maintain their health, independence, and quality of life. At Amen Family Medicine, the philosophy is that primary care should be proactive rather than reactive.
Lauren Malloy was a baby when her mother, Lori, was murdered in East Providence, Rhode Island. For thirty years, no one told her. Everyone said Lori died of natural causes. Then a stranger sent Lauren a message — and the lie collapsed. Now Lauren is investigating her own mother's murder. She's recorded hundreds of hours of interviews with law enforcement, family, childhood friends, and people who won't stop contradicting each other. Every answer opens a darker question. Every person she trusts seems to be hiding something. And the closer she gets to the truth, the more she realizes the people she trusts may be the ones with the most to hide. A 10-part true crime investigation hosted by the victim's daughter. Lauren's mission: to finally uncover the identity of Lori's killer. Audible subscribers can binge all 10 episodes early and ad-free right now. Join Audible in the Audible App or by subscribing on Apple Podcasts. Listen now: HERE See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Lauren Malloy was a baby when her mother, Lori, was murdered in East Providence, Rhode Island. For thirty years, no one told her. Everyone said Lori died of natural causes. Then a stranger sent Lauren a message — and the lie collapsed. Now Lauren is investigating her own mother's murder. She's recorded hundreds of hours of interviews with law enforcement, family, childhood friends, and people who won't stop contradicting each other. Every answer opens a darker question. Every person she trusts seems to be hiding something. And the closer she gets to the truth, the more she realizes the people she trusts may be the ones with the most to hide. A 10-part true crime investigation hosted by the victim's daughter. Lauren's mission: to finally uncover the identity of Lori's killer. Audible subscribers can binge all 10 episodes early and ad-free right now. Join Audible in the Audible App or by subscribing on Apple Podcasts. Listen now: HERE See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
© 2020-2026 Ivy Podcast Discovery LLC
